G

GT Biopharma
D

GTBP

2.13000
USD
0.00
(0.00%)
مغلق
حجم التداول
206
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
4,759,119
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: GT Biopharma

القطاع: Healthcare
الصناعة: Biotechnology
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.